Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 4, 1996, Pages 399-406

  Knudsen, Lene Meldgaard ^a   Gaarsdal, Eva ^a   Jensen, Linda ^a   Nielsen, Kirsten Junker ^a   Nikolaisen, Kirsten ^a   Johnsen, Hans E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOTRANSPLANTATION; CHRONOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELLS; BLOOD TRANSFUSION, AUTOLOGOUS; BONE MARROW; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; EPIRUBICIN; ETOPOSIDE; FEMALE; FILGRASTIM; FLUOROURACIL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELLS; HUMANS; INJECTIONS, SUBCUTANEOUS; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MELPHALAN; MIDDLE AGED; NEOPLASMS;

EID: 0029758142     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.399     Document Type: Article

References (27)

1. Juttner, C.A., To, L.B., Ho, J.Q.K., et al. Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute nonlymphoblastic leukemia. Transplant Proc. 20:40, 1988.
2. Brice, P., Divine, M., Marolleau, J.P., et al. Comparison of autografting using mobilized peripheral blood stem cells with and without granulocyte colony-stimulating factor in malignant lymphomas. Bone Marrow Transplant. 14:51, 1994.
3. Fermand, J.P., Chevret, S., Ravaud, P., et al. High-dose chemotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients. Blood 82:2005, 1993.
4. Elias, A.D., Ayash, L., Anderson, K.C., et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992.
5. Henon, P.R., Liang, H., Beck-Wirth, G., et al. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant. 9:285, 1992.
6. Chao, N.J., Schriber, J.R., Grimes, K., et al. Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993.
7. Roos, A.A., Cooper, B.W., Lazarus, H.M., et al. Detection and viability of tumor cells in peripheral blood stem cell collection from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82:2605, 1993.
8. Brugger, W., Brass, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
9. Richman, C.M., Weiner, R.S., & Yankee, R.A. Increase in circulating stem cells following chemotherapy in man. Blood 47:1031, 1976.
10. Socinski, M.A., Elias, A., Schnipper, L., et al. Granulocyte-macrophage colony-stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1:1194, 1988.
11. Peters, W.P., Rosner, G., Ross, M., et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy. Blood 81:1709, 1993.
12. Siena, S., Bregni, M., Brando, M., et al. Circulation of CD34+ hematopoietic stem cells in the periphereal blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte macrophage colony-stimulating factor. Blood 74:1905, 1989.
13. Ho, A.D., Glück, S., Germond, C., et al. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 7:1738, 1993.
14. Pierelle, L., Iacone, A., Quaglietta, A.M., et al. Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: A multicentre retrospective study. Br. J. Haematol. 86:70, 1994.
15. Jones, H.M., Jones, S.A., Watts, M.J., et al. Development of a simplified single-apheresis approach for peripheral blood progenitor cell transplantation in previously treated patients with lymphoma. J. Clin. Oncol. 12:1693, 1994.
16. Henon, P.R., Debecker, A., Lepers, M., et al. Collection of circulating stem cells and their use for autograft in adults with acute lymphoblastic leukemia. Nouv. Rev. Fr. Hématol. 30:229, 1988.
17. Serke, S., Säuberlich, S. & Huhn, D. Multiparameter flow cytometrical quantitation of circulating CD34+ cells: Correlation to the quantitation of circulating haemopoietic progenitor cells in vitro colony assay. Br. J. Haematol. 77:453, 1991.
18. Tilly, H., Bastis, D., Lucet, J.C., et al. Haemopoietic reconstitution after autologous peripheral blood stem cell transplantation in acute leukemia. Lancet 2:154, 1986.
19. Stiff, P.J., Koesteer, A.R. & Lanzotti, V.J. Autologous transplantation using peripheral blood stem cells. Exp. Hematol. 14:311, 1986.
20. Bensinger, W.I., Longin, K., Appelbaum, F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br. J. Haematol. 87:825, 1994.
21. To, L.B., Sheppard, K.M., Haylock, D.N., et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp. Hematol. 18:442, 1990.
22. Johnsen, H.E., for the laboratories associated with the Nordic Myeloma Study Group (NMSG). Report from a Nordic workshop on CD34+ cell analysis: Technical recommendations for progenitor estimation in leukapheresis from multiple myeloma patients. J. Hematother. 4:21, 1995.
23. Haas, R., Hohaus, S., Ehrhardt, R., et al. Mobilization of blood stem cells with recombinant human (rh) G-CSF in patients with hematological malignancies and solid tumors. In Peripheral Blood Stem Cell Autografts, eds. Wunder, E.W. & Henon, P.R. Springer-Verlag, Berlin, 1993, p. 155.
24. Möhle, R., Pförsich, M., Fruehauf, S., et al. Filgrastim post-chemotherapy mobilizes more CD34+ cells with a different antigenic profile compared with the use during steady-state hematopoiesis. Bone Marrow Transplant. 14:827, 1994.
25. Jensen, K.E., Hansen, P.B., Larsen, V.A., et al. Short-term myeloid growth factor mediated expansion of bone marrow haematopoiesis studied by localized magnetic resonance proton spectroscopy. Br. J. Haematol. 88:465, 1994.
26. Shepherd, K.M., Charles, P., Sage, R.E., et al. Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies. Clin. Lab. Haematol. 13:25, 1991.
27. Kotasek, D., Shepherd, K.M., Sage, R.E., et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant. 9:11, 1992.